Nasef, Sherif A.; Shaaban, A. Aziz; Mould-Quevedo, Joaquin - In: Health Economics Review 5 (2015) 13, pp. 1-8
Background: Cyclooxygenase (COX)-2 inhibitors including celecoxib are as effective as non-selective non-steroidal anti … celecoxib versus ns-NSAIDs, with/without proton-pump inhibitor (PPI) co-therapy, for managing OA in Saudi Arabian subjects aged … with relative risks of adverse events using CONDOR trial data, was adapted. Patients received celecoxib or ns-NSAIDs, with …
